Serum glucagon, bile acids, and FGF-19: metabolic behavior patterns after Roux-en-Y gastric bypass and vertical sleeve gastrectomy
Metabolic/bariatric surgery is a highly effective treatment for obesity and metabolic diseases. Serum glucagon, bile acids, and FGF-19 are key effectors of various metabolic processes and may play central roles in bariatric surgical outcomes. It is unclear whether these factors behave similarly afte...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 2021
|
| In: |
Obesity surgery
Year: 2021, Jahrgang: 31, Heft: 11, Pages: 4939-4946 |
| ISSN: | 1708-0428 |
| DOI: | 10.1007/s11695-021-05677-3 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11695-021-05677-3 |
| Verfasserangaben: | Cui Yang, Julia Brecht, Christel Weiß, Christoph Reissfelder, Mirko Otto, Jane N. Buchwald, Georgi Vassilev |
| Zusammenfassung: | Metabolic/bariatric surgery is a highly effective treatment for obesity and metabolic diseases. Serum glucagon, bile acids, and FGF-19 are key effectors of various metabolic processes and may play central roles in bariatric surgical outcomes. It is unclear whether these factors behave similarly after Roux-en-Y gastric bypass (RYGB) vs vertical sleeve gastrectomy (VSG). |
|---|---|
| Beschreibung: | Published online: 30 August 2021 Gesehen am 02.06.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 1708-0428 |
| DOI: | 10.1007/s11695-021-05677-3 |